JP Morgan initiated coverage on EndoChoice's stock, according to a Trade Calls report.
Here are three points:
1. The firm rated EndoChoice shares "overweight."
2. The 52-week high of the stock is $17.15, while the 52-week low is $3.64.
3. The market cap of the company is $129 million.